215 related articles for article (PubMed ID: 1668145)
21. The immunoglobulin kappa locus contains a second, stronger B-cell-specific enhancer which is located downstream of the constant region.
Meyer KB; Neuberger MS
EMBO J; 1989 Jul; 8(7):1959-64. PubMed ID: 2507312
[TBL] [Abstract][Full Text] [Related]
22. Transcription cell type specificity is conferred by an immunoglobulin VH gene promoter that includes a functional consensus sequence.
Mason JO; Williams GT; Neuberger MS
Cell; 1985 Jun; 41(2):479-87. PubMed ID: 3921262
[TBL] [Abstract][Full Text] [Related]
23. HS1,2 enhancer regulation of germline epsilon and gamma2b promoters in murine B lymphocytes: evidence for specific promoter-enhancer interactions.
Laurencikiene J; Deveikaite V; Severinson E
J Immunol; 2001 Sep; 167(6):3257-65. PubMed ID: 11544313
[TBL] [Abstract][Full Text] [Related]
24. B cell-specific demethylation: a novel role for the intronic kappa chain enhancer sequence.
Lichtenstein M; Keini G; Cedar H; Bergman Y
Cell; 1994 Mar; 76(5):913-23. PubMed ID: 8124725
[TBL] [Abstract][Full Text] [Related]
25. Nuclear factor NF-kappa B can interact functionally with its cognate binding site to provide lymphoid-specific promoter function.
Wirth T; Baltimore D
EMBO J; 1988 Oct; 7(10):3109-13. PubMed ID: 3141147
[TBL] [Abstract][Full Text] [Related]
26. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes.
Singh H; Sen R; Baltimore D; Sharp PA
Nature; 1986 Jan 9-15; 319(6049):154-8. PubMed ID: 3079885
[TBL] [Abstract][Full Text] [Related]
27. Induction of human interferon gene expression is associated with a nuclear factor that interacts with the NF-kappa B site of the human immunodeficiency virus enhancer.
Hiscott J; Alper D; Cohen L; Leblanc JF; Sportza L; Wong A; Xanthoudakis S
J Virol; 1989 Jun; 63(6):2557-66. PubMed ID: 2542571
[TBL] [Abstract][Full Text] [Related]
28. The immunoglobulin heavy-chain enhancer functions as the promoter for I mu sterile transcription.
Su LK; Kadesch T
Mol Cell Biol; 1990 Jun; 10(6):2619-24. PubMed ID: 2111440
[TBL] [Abstract][Full Text] [Related]
29. A ubiquitous enhancer shared by two promoters in the human aldolase A gene.
Concordet JP; Maire P; Kahn A; Daegelen D
Nucleic Acids Res; 1991 Aug; 19(15):4173-80. PubMed ID: 1651479
[TBL] [Abstract][Full Text] [Related]
30. YY1 binds to the E3' enhancer and inhibits the expression of the immunoglobulin κ gene via epigenetic modifications.
Zhou X; Xian W; Zhang J; Zhu Y; Shao X; Han Y; Qi Y; Ding X; Wang X
Immunology; 2018 Dec; 155(4):491-498. PubMed ID: 30098214
[TBL] [Abstract][Full Text] [Related]
31. In vitro transcription of immunoglobulin genes in a B-cell extract: effects of enhancer and promoter sequences.
Sen R; Baltimore D
Mol Cell Biol; 1987 May; 7(5):1989-94. PubMed ID: 3110599
[TBL] [Abstract][Full Text] [Related]
32. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
Duan H; Heckman CA; Boxer LM
Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
[TBL] [Abstract][Full Text] [Related]
33. Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif.
Henthorn P; Kiledjian M; Kadesch T
Science; 1990 Jan; 247(4941):467-70. PubMed ID: 2105528
[TBL] [Abstract][Full Text] [Related]
34. Stereoalignment requirements for activation of transcription by the simian virus 40 enhancer.
Schatz C; Chatton B
Nucleic Acids Res; 1990 Feb; 18(3):421-7. PubMed ID: 2155399
[TBL] [Abstract][Full Text] [Related]
35. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages.
Shakhov AN; Collart MA; Vassalli P; Nedospasov SA; Jongeneel CV
J Exp Med; 1990 Jan; 171(1):35-47. PubMed ID: 2104921
[TBL] [Abstract][Full Text] [Related]
36. Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells.
Polack A; Feederle R; Klobeck G; Hörtnagel K
EMBO J; 1993 Oct; 12(10):3913-20. PubMed ID: 8404859
[TBL] [Abstract][Full Text] [Related]
37. Cell-type preference of immunoglobulin kappa and lambda gene promoters.
Picard D; Schaffner W
EMBO J; 1985 Nov; 4(11):2831-8. PubMed ID: 2998757
[TBL] [Abstract][Full Text] [Related]
38. The MLV and SV40 enhancers have a similar pattern of transcriptional activation.
Augereau P; Wasylyk B
Nucleic Acids Res; 1984 Dec; 12(23):8801-18. PubMed ID: 6096807
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional control of the invariant chain gene involves promoter and enhancer elements common to and distinct from major histocompatibility complex class II genes.
Zhu L; Jones PP
Mol Cell Biol; 1990 Aug; 10(8):3906-16. PubMed ID: 2115116
[TBL] [Abstract][Full Text] [Related]
40. The immunoglobulin octanucleotide: independent activity and selective interaction with enhancers.
Parslow TG; Jones SD; Bond B; Yamamoto KR
Science; 1987 Mar; 235(4795):1498-501. PubMed ID: 3029871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
